Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Analysts on Wall Street project that Collegium Pharmaceutical (COLL) will announce quarterly earnings of $1.54 per share in its forthcoming report, representing a decline of 2.5$180.4 million, increasing 20.5% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections dur ...